Not eligible after your consult
Semaglutide for Weight Loss Semaglutide has been found to be effective in promoting weight loss in overweight and obesity
Tirzepatide addresses this inflammatory burden directly and profoundly
Lam, S., Lindsey, J., Carranza Leon, B
Common gastrointestinal side effects include: Nausea and vomiting : Usually most pronounced during initial treatment and dose escalation, often improving over 48 weeks Diarrhoea or constipation : Can affect hydration and nutritional status Abdominal discomfort : Typically mild and transient Patients can manage mild gastrointestinal symptoms by eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the medication as directed
Compounded semaglutide activates GLP-1 receptors in your brain within hours of injection, but the timeline for noticing effects varies by individual metabolism and starting dose